This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1994:241:385-94.

doi: 10.1016/0076-6879(94)41075-5.

Qualitative study of drug resistance in retroviral protease using structural modeling and site-directed mutagenesis

J C Culberson¹, B L Bush, V V Sardana

Affiliations

PMID: 7854190
DOI: 10.1016/0076-6879(94)41075-5

Review

Qualitative study of drug resistance in retroviral protease using structural modeling and site-directed mutagenesis

J C Culberson et al. Methods Enzymol. 1994.

. 1994:241:385-94.

doi: 10.1016/0076-6879(94)41075-5.

Authors

J C Culberson¹, B L Bush, V V Sardana

Affiliation

¹ Department of Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486.

PMID: 7854190
DOI: 10.1016/0076-6879(94)41075-5

No abstract available

PubMed Disclaimer

Similar articles

X-ray structures of retroviral proteases and their inhibitor-bound complexes.
Ringe D. Ringe D. Methods Enzymol. 1994;241:157-77. doi: 10.1016/0076-6879(94)41064-x. Methods Enzymol. 1994. PMID: 7854176 No abstract available.
Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.
Tomasselli AG, Heinrikson RL. Tomasselli AG, et al. Methods Enzymol. 1994;241:279-301. doi: 10.1016/0076-6879(94)41069-0. Methods Enzymol. 1994. PMID: 7854182 Review. No abstract available.
Stability of dimeric retroviral proteases.
Darke PL. Darke PL. Methods Enzymol. 1994;241:104-27. doi: 10.1016/0076-6879(94)41062-3. Methods Enzymol. 1994. PMID: 7854174 Review.
Time dependent heterodimer formation leads to inhibition of HIV protease activity.
Babé LM, Craik CS. Babé LM, et al. Adv Exp Med Biol. 1991;306:543-7. doi: 10.1007/978-1-4684-6012-4_74. Adv Exp Med Biol. 1991. PMID: 1812756 No abstract available.
Molecular modeling of the HIV-2 protease.
Gustchina A, Weber IT, Wlodawer A. Gustchina A, et al. Adv Exp Med Biol. 1991;306:549-53. doi: 10.1007/978-1-4684-6012-4_75. Adv Exp Med Biol. 1991. PMID: 1812757 No abstract available.

See all similar articles

Cited by

Modeling combinations of antiretroviral agents in vitro with integration of pharmacokinetics: guidance in regimen choice for clinical trial evaluation.
Drusano GL, Prichard M, Bilello PA, Bilello JA. Drusano GL, et al. Antimicrob Agents Chemother. 1996 May;40(5):1143-7. doi: 10.1128/AAC.40.5.1143. Antimicrob Agents Chemother. 1996. PMID: 8723455 Free PMC article.
Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase.
McDougall B, King PJ, Wu BW, Hostomsky Z, Reinecke MG, Robinson WE Jr. McDougall B, et al. Antimicrob Agents Chemother. 1998 Jan;42(1):140-6. doi: 10.1128/AAC.42.1.140. Antimicrob Agents Chemother. 1998. PMID: 9449274 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information